Morphogen Delivery by Osteoconductive Nanoparticles Instructs Stromal Cell Spheroid Phenotype.

MSCs often lose their osteogenic traits when transplanted due to the absence of osteoinductive signals. While spheroid formation helps, it does not fully preserve these traits. Prior research has shown that MSC spheroids can maintain some osteogenic features, but this gap motivated the need for a more effective delivery system. This uncertainty drove the development of methods to prolong the effects of osteogenic factors. No prior work had resolved how to maintain osteogenic cues in transplanted MSCs. This gap motivated the exploration of nanoparticle-based delivery systems. That uncertainty drove the investigation into combining osteoconductive and osteoinductive signals. This uncertainty drove the search for a strategy to retain MSC osteogenic potential.

The aim of this study was to develop a delivery system that prolongs osteogenic signals in MSC spheroids. MSCs lose their osteogenic traits when transplanted, so this problem required a solution. The specific problem was maintaining MSC osteogenic differentiation after transplantation. The motivation was to improve cell-based therapies for bone regeneration. The goal was to combine osteoconductive and osteoinductive signals. The approach was to use HA nanoparticles loaded with BMP-2. The objective was to test if this system could maintain osteogenic traits in spheroids. The hypothesis was that BMP-2-loaded HA could better preserve MSC osteogenic potential.

BMP-2 was adsorbed onto HA nanoparticles for delivery to MSC spheroids. MSC spheroids were formed and tested under osteogenic conditions. The osteogenic phenotype was evaluated in the absence of other osteogenic cues. HA nanoparticle incorporation was optimized at lower concentrations. BMP-2 dosage was adjusted based on initial morphogen concentration. ALP activity and osteocalcin expression were measured in spheroids. Spheroids with uncoated HA nanoparticles served as controls. The spatial distribution of osteogenic markers was compared between groups.

MSC spheroids with BMP-2-loaded HA showed higher ALP activity than controls. Osteocalcin expression was more uniform in spheroids with BMP-2-loaded HA. Differentiation was limited to the periphery in spheroids with soluble BMP-2. Spheroids with BMP-2-loaded HA retained osteogenic traits after cue removal. ALP activity was significantly elevated in BMP-2-loaded HA spheroids. Osteocalcin was more evenly distributed in BMP-2-loaded HA groups. Spheroids with uncoated HA had less uniform osteocalcin expression. These findings suggest that BMP-2-loaded HA improves MSC osteogenic retention.

The authors propose that BMP-2-loaded HA nanoparticles improve MSC osteogenic retention. These findings suggest that this system could enhance cell-based therapies for bone regeneration. The authors suggest that combining osteoconductive and osteoinductive signals is beneficial. The authors propose that HA nanoparticles can deliver BMP-2 more effectively. The authors suggest that this system may better retain MSC osteogenic traits. The authors propose that this approach could improve MSC participation in bone formation. The authors suggest that this delivery system may prolong osteogenic signals in transplanted MSCs. These findings may represent a promising strategy for bone regeneration therapies.